公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2003 | Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Gastroenterology | 491 | 437 | |
2007 | Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: A comparison with chronic carriers | Tong M.J.; Blatt L.M.; JIA-HORNG KAO ; Cheng J.T.; Corey W.G. | Liver International | 82 | 75 | |
2005 | Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B | Lin C.-L.; Liao L.-Y.; Wang C.-S.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 72 | 64 | |
2014 | Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients | Wang C.-C.; TAI-CHUNG TSENG ; Wang P.-C.; Lin H.H.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 10 | 10 | |
2020 | Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy | TAI-CHUNG TSENG ; Peng C.-Y; Hsu Y.-C; TUNG-HUNG SU ; Wang C.-C; CHUN-JEN LIU ; HUNG-CHIH YANG ; Yang W.-T; Lin C.-H; Yu M.-L; Lai H.-C; Tanaka Y; Nguyen M.H; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver Cancer | 17 | 13 | |
2017 | Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B | Wei L.; JIA-HORNG KAO | Current Medical Research and Opinion | 14 | 12 | |
1997 | Benign recurrent intrahepatic cholestasis | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; TSUI-LIEN MAO ; Wang T.-H.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 1 | 0 | |
2013 | Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients | Huang Y.-W.; Hu J.-T.; Hu F.-C.; Chang C.-J.; Chang H.-Y.; JIA-HORNG KAO ; Yang S.-S.; DING-SHINN CHEN | Antiviral Therapy | 8 | 8 | |
1997 | Blood-bank screening for hepatitis G [14] | JIA-HORNG KAO ; PEI-JER CHEN ; JIN-TOWN WANG ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 7 | 5 | |
2018 | Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan | Hsieh M.-H.; Yeh M.-L.; TUNG-HUNG SU ; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; Yu M.-L. | Journal of the Formosan Medical Association | 5 | 4 | |
2009 | Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease | Hsu C.-S.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 0 | 0 | |
1998 | Brief communication: Efficacy of ribavirin plus interferon α on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon α alone | JIA-HORNG KAO ; Lai M.-Y.; Chen W.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 10 | 10 | |
2015 | Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B? | Lin C.-L.; JIA-HORNG KAO | Hepatology (Baltimore, Md.) | 1 | 1 | |
2009 | Capsule endoscopy versus colonoscopy | Hsu C.-S.; JIA-HORNG KAO | New England Journal of Medicine | 0 | ||
2010 | Carvedilol versus variceal band ligation for prevention of the first variceal bleed | Wang C.-C.; JIA-HORNG KAO | Hepatology | 0 | 0 | |
2021 | The case for simplifying and using absolute targets for viral hepatitis elimination goals | Razavi H.; Blach S.; Razavi-Shearer D.; Abaalkhail F.; Abbas Z.; Abdallah A.; Abrao Ferreira P.; Abu Raddad L.J.; Adda D.; Agarwal K.; Aghemo A.; Ahmed A.; Al-Busafi S.A.; Al-hamoudi W.; Al-Kaabi S.; Al-Romaihi H.; Aljarallah B.; AlNaamani K.; Alqahtani S.; Alswat K.; Altraif I.; Asselah T.; Bacon B.; Bessone F.; Bizri A.R.; Block T.; Bonino F.; Brandão-Mello C.E.; Brown K.; Bruggmann P.; Brunetto M.R.; Buti M.; Cabezas J.; Calleja J.L.; Castro Batänjer E.; Chan H.L.-Y.; Chang H.; Chen C.-J.; Christensen P.B.; Chuang W.-L.; Cisneros L.; Cohen C.; Colombo M.; Conway B.; Cooper C.; Craxi A.; Crespo J.; Croes E.; Cryer D.; Cupertino de Barros F.P.; Derbala M.; Dillon J.; Doss W.; Dou X.; Doyle J.; Duberg A.-S.; Dugan E.; Dunn R.; Dusheiko G.; El Khayat H.; El-Sayed M.H.; Eshraghian A.; Esmat G.; Esteban Mur R.; Ezzat S.; Falconer K.; Fassio E.; Ferrinho P.; Flamm S.; Flisiak R.; Foster G.; Fung J.; García-Samaniego J.; Gish R.G.; Gonçales F.; Halota W.; Hamoudi W.; Hassany M.; Hatzakis A.; Hay S.; Himatt S.; Hoepelman I.M.; Hsu Y.-C.; Hui Y.T.; Hunyady B.; Jacobson I.; Janjua N.; Janssen H.; Jarcuska P.; Kabagambe K.; Kanto T.; JIA-HORNG KAO ; Kaymakoglu S.; Kershenobich D.; Khamis F.; Kim D.J.; Kim D.Y.; Kondili L.A.; Kottilil S.; Kramvis A.; Kugelmas M.; Kurosaki M.; Lacombe K.; Lagging M.; Lao W.-C.; Lavanchy D.; Lazarus J.V.; Lee A.; Lee S.S.; Levy M.; Liakina V.; Lim Y.-S.; Liu S.; Maddrey W.; Malekzadeh R.; Marinho R.T.; Mathur P.; Maticic M.; Mendes Correa M.C.; Mera J.; Merat S.; Mogawer S.; Mohamed R.; Muellhaupt B.; Muljono D.; Mostafa I.; Nahum M.S.; Nawaz A.; Negro F.; Ninburg M.; Ning Q.; Ntiri- Reid B.; Nymadawa P.; Oevrehus A.; Ormeci N.; Orrego M.; Osman A.; Oyunsuren T.; Pan C.; Papaevangelou V.; Papatheodoridis G.; Popping S.; Prasad P.; Prithiviputh R.; Qureshi H.; Ramji A.; Razavi-Shearer K.; Reddy R.; Remak W.; Richter C.; Ridruejo E.; Robaeys G.; Roberts S.; Roberts L.; Roudot-Thoraval F.; Saab S.; Said S.; Salamat A.; Sanai F.; Sanchez-Avila J.F.; Schiff E.; Schinazi R.; Sebastiani G.; Seguin-Devaux C.; Shanmugam R.P.; Sharara A.; Shilton S.; Shouval D.; Sievert W.; Simonova M.; Sohrabpour A.A.; Sonderup M.; Soza A.; Wendy Spearman C.; Steinfurth N.; Sulkowski M.; Tan S.-S.; Tanaka J.; Tashi D.; Thein H.-H.; Thompson P.; Tolmane I.; Toy M.; Valantinas J.; Van de Vijver D.; Vélez-Möller P.; Vince A.; Waked I.; Wang S.; Wedemeyer H.; Wong V.; Xie Q.; Yamada S.; Yang H.-I.; Yesmembetov K.; Yilmaz Y.; Younossi Z.; Yu M.-L.; Yuen M.-F.; Yurdaydin C.; Yusuf A.; Zekry A.; Zeuzem S.; Polaris Observatory Collaborators | Journal of Viral Hepatitis | 25 | 22 | |
2006 | Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C | Yang S.-S.; Fu L.-S.; Chang C.-S.; Yeh H.-Z.; Chen G.-H.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 17 | 17 | |
2005 | Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia | JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 100 | 88 | |
2021 | Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study | Yu M.-L.; Tsai W.-L.; Chu C.-J.; JIA-HORNG KAO | Kaohsiung Journal of Medical Sciences | 1 | 1 | |
2016 | Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model | Li Y.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; Cheng H.-R.; YUNG-MING JENG ; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Wu H.-L. | Oncotarget | 4 | 4 |